Filter Results:
(1,871)
Show Results For
- All HBS Web
(1,871)
- People (2)
- News (438)
- Research (1,056)
- Events (4)
- Multimedia (4)
- Faculty Publications (389)
Show Results For
- All HBS Web
(1,871)
- People (2)
- News (438)
- Research (1,056)
- Events (4)
- Multimedia (4)
- Faculty Publications (389)
- 01 Mar 2004
- News
Ex-Con Talks Ethics with HBS Students
dropped out of college and joined a New York securities firm. He saw his sales and commissions rise after he decided to be less than forthcoming about potential drawbacks to the investment ideas he was pitching to customers. Over time,... View Details
- 08 Nov 2024
- Op-Ed
How Private Investors Can Help Solve Africa's Climate Crisis
investors and business leaders, and very few were interested in “green” activities or even environmental, social, and governance initiatives on their own merits, since in many cases, they don’t lead to incremental revenue increases or... View Details
- January 2022
- Background Note
The Florange Law: Encouraging Long-Termism in Equity Markets?
By: Charles C.Y. Wang and Tonia Labruyere
This note provides background information on a French law (“the Florange law”) passed in 2014 that the French government said would encourage long-term shareholdings. The note describes the law, what led to it, the reactions it evoked, and similar initiatives in other... View Details
Keywords: Equity; Financial Markets; Investment Activism; Institutional Investing; Corporate Governance; Policy; Rights; Laws and Statutes; Business and Government Relations; Accounting Industry; France
Wang, Charles C.Y., and Tonia Labruyere. "The Florange Law: Encouraging Long-Termism in Equity Markets?" Harvard Business School Background Note 122-065, January 2022.
- November 2007 (Revised October 2009)
- Case
Ligand Pharmaceuticals Incorporated
In an activist role, the hedge fund Third Point LLC has three board seats and an ownership stake of 9.5% in Ligand Pharmaceuticals, Inc., a specialty pharmaceutical company. Third Point believed that Ligand had a strong drug portfolio and pipeline but that it was... View Details
Keywords: Mergers and Acquisitions; Private Equity; Investment Activism; Investment Funds; Governing and Advisory Boards; Bids and Bidding; Ownership Stake; Pharmaceutical Industry; United States
El-Hage, Nabil N., and Michael Gorzynski. "Ligand Pharmaceuticals Incorporated." Harvard Business School Case 208-019, November 2007. (Revised October 2009.)
- Profile
Jessey Jin
prepared you for your current role & your long term career? The idea of helping students prepare for a long term career can be found in case discussion, club events, alumni activities and so on. The school put together lots of... View Details
- November 2019
- Supplement
United Technologies Corp.: Are the Parts Worth More Than the Whole?
By: Benjamin C. Esty and Daniel Fisher
After spending more than 50 years creating a diversified industrial conglomerate that Fortune Magazine described as “arguably the most profitable conglomerate in America” in 2014, UTC’s CEO Greg Hayes was under pressure from activist investors (Dan Loeb and Bill... View Details
Keywords: Corporate Strategy; Business Conglomerates; Financial Management; Corporate Governance; Organizational Structure; Diversification; Valuation; Investment Activism; Financial Strategy; Investment Funds; Value Creation; Aerospace Industry; Electronics Industry; Industrial Products Industry; United States
- January 2016 (Revised January 2019)
- Supplement
The Allergan Board Under Fire (B)
By: Lynn S. Paine, Suraj Srinivasan, John C. Coates and David Lane
In 2014, the Allergan Inc. board of directors received a surprise takeover offer from Valeant Pharmaceuticals in alliance with hedge fund activist Bill Ackman's Pershing Square Capital Management. In the unprecedented arrangement between an acquirer and a hedge fund... View Details
Keywords: Allergan, Inc.; Valeant; Ackman; Pershing Square; Tender Offer; Activist Investors; Business Models; R＆D; Board Of Directors; Securities Litigation; Acquisition Strategy; Takeover Defenses; Hedge Funds; Shareholder Rights; Proxy Contest; Shareholder Special Meetings; Legal Issues In Contested Takeovers; Corporate Governance; Investment Activism; Business and Stakeholder Relations; Business Model; Business and Shareholder Relations; Valuation; Pharmaceutical Industry
Paine, Lynn S., Suraj Srinivasan, John C. Coates, and David Lane. "The Allergan Board Under Fire (B)." Harvard Business School Supplement 316-029, January 2016. (Revised January 2019.)
- October 2010
- Teaching Note
Target Corporation: Ackman versus the Board (TN)
By: Krishna G. Palepu and Suraj Srinivasan
Teaching Note for 109010. View Details
- 2002
- Book
Searching for a Corporate Savior: The Irrational Quest for Charismatic CEOs
By: Rakesh Khurana
Corporate CEOs are headline news. Stock prices rise and fall at word of their hiring and firing. Business media debate their merits and defects as if individual leaders determined the health of the economy. Yet we know surprisingly little about how CEOs are selected... View Details
Keywords: Managerial Roles; Selection and Staffing; Personal Characteristics; Experience and Expertise; Investment Activism; Corporate Strategy
Khurana, Rakesh. Searching for a Corporate Savior: The Irrational Quest for Charismatic CEOs. Princeton, NJ: Princeton University Press, 2002.
- 25 Aug 2022
- News
Open Market
first focusing on scaling operations and then becoming a partner at Google Capital (now CapitalG), investing in late-stage tech companies and helping founders grow their businesses. The experience at Google was revelatory, with Howard... View Details
- Web
HBS - Financials | Consolidated Balance Sheet
2021 Annual Report From The Dean Financials PDF Downloads Archive Financials 5 Year Summary From the CFO Financial Highlights Statement of Activity & Cash Flows Consolidated Balance Sheet Supplemental Financial Information Financials 5... View Details
- 01 Dec 2012
- News
Corruption 101
investment firm seeking a high-impact agribusiness project in rural Africa. A small company in Tanzania seems to fit the bill, but it faces health-safety issues with the potential to spread E. coli throughout the region. Another problem:... View Details
- 01 Jun 2011
- News
Faculty Books
Lecturer Robert Pozen and his coauthor detail how mutual funds are marketed, regulated, and invested in stocks and bonds. They describe the critical factors needed to choose a specific fund, including what to look for when reading... View Details
- Web
HBS - Financials | Consolidated Balance Sheet
2023 Annual Report From The Dean Key Metrics Financials PDF Downloads Financials From the CFO Financial Highlights Statement of Activity & Cash Flows Consolidated Balance Sheet Supplemental Financial Information Financials From the CFO... View Details
- 01 Dec 1998
- News
A Journey to Leadership: Luke O'Neill
combines academic and experiential learning and involves students in activities as diverse as constructing solar panels, producing maple syrup, and delivering emergency medical care in search-and-rescue situations. "Our educational goal,"... View Details
Keywords: Deborah Blagg
- 29 Jan 2021
- News
Holding Business to Account
behind-the-scenes work of impact investment firms and the wins that aren’t so public. “There’s been so much work done with regard to indigenous people’s rights everywhere, from the Amazon to the Dakota Access Pipeline,” she says by way of... View Details
- March 2009 (Revised September 2010)
- Case
HOYA Corporation (A)
By: W. Carl Kester and Masako Egawa
In 2007, HOYA of Japan must decide whether to change its friendly exchange offer for Pentax into a hostile cash tender offer. A surprising sequence of events had caused a friendly merger agreement to fall apart, resulting in a boardroom coup at Pentax and the... View Details
Keywords: Mergers and Acquisitions; Investment Activism; Corporate Governance; Governance Controls; Governing and Advisory Boards; Negotiation Tactics; Business and Shareholder Relations; Valuation; Japan
Kester, W. Carl, and Masako Egawa. "HOYA Corporation (A)." Harvard Business School Case 209-065, March 2009. (Revised September 2010.)
- March 2013
- Supplement
HOYA Corporation (A)
By: W. Carl Kester
- Fast Answer
Biotech and medical devices: Company Data and Analysis
Insights & Industry Analytics - Tracks global venture capital, angel investment, private equity, M&A, and IPO activity related to private companies and emerging spaces. Pitchbook - Information on companies, deals, funds, investors... View Details
- 11 Apr 2007
- Research & Ideas
Adding Time to Activity-Based Costing
be possible without the power of ERP systems. Many companies invested tens or hundreds of millions in their ERP systems but found it difficult to identify a return on investment from their spending.... View Details
Keywords: by Sarah Jane Gilbert